Option chain shows key data for Genmab's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Genmab.

Genmab (OTC:GNMSF) Stock, Option Chain

Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Biotech

News

Health Care

General

GNMSF

GlaxoSmithKline plc (NYSE: GSK) announced Wednesday the United States Food and Drug Administration had approved its cancer drug aimed at treating refractory multiple myeloma in adults.

GlaxoSmithKline Gets FDA Approval For Blood Cancer Drug

Intraday Update

Markets

Movers

Trading Ideas

ABMBF

ACGLP

AGXKF

AMGN

APPS

ATEYY

AURI

CANVF

CASY

CHCT

CORR

CRCUF

CSGP

CVNA

DCPH

DPMLF

EMLAF

EXPGF

FIVN

FLXT

FORTY

GLDLF

GMAB

GNRC

GZTGF

HALL

HCAT

HEI-A

HLTEF

INTZ

JBSAY

KELYA

KRYAF

MHGVY

MISVF

Nuveen Insured Tax-Free Advantage Municipal Fund

NEPH

Nuveen Insured Dividend Advantage Municipal Fund

PEGI

PERI

PLMR

PTPIF

QMCO

RADA

ROKU

SBAC

SEDG

SHAK

SLVRF

SPNS

SWCH

SWPRF

TCEGF

TERP

TMCX

TNAV

TPCS

TRXD

VCISF

WDFC

ZURVY

RBTEF

AMANF

CGECF

PSLV

TRZBF

DNCVF

Stocks That Hit 52-Week Highs Of Tuesday

ALVVF

APRO

ATEC

AVXT

BBBXF

BLHEY

BMCH

CBOE

CETV

CHPGF

CINF

CLSI

CMXC

CNMD

COLD

CONC

CUBE

CYRX

EVRG

FERN

GOLD

GRWG

HLND

IMOS

ITMC

MIRM

MXSG

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

Nuveen New Jersey Dividend Advantage Municipal Fund

Nuveen Dividend Advantage Municipal Fund 3

ORZCF

PFGC

PMSNF

PODD

PRNB

RGLD

RNSGF

ROGFF

TORXF

WELL

WKLDF

PSTO

CSPCY

SILV

Stocks That Hit 52-Week Highs Of Monday

Genmab AS

Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab

Harding Loevner International Equity Q2 2024 Report

Harding Loevner International Equity ADR Q2 2024 Report

Harding Loevner International Developed Markets Equity Q2 2024 Report

Undercovered Dozen: United Natural Foods, Procter & Gamble, Archer Aviation, Embraer +

Baird Q3 2024 International And Global Growth Fund Commentary

Genmab A/S 2024 Q3 - Results - Earnings Call Presentation

Genmab A/S (GMAB) Q3 2024 Earnings Conference Call Transcript

Harding Loevner International Equity ADR Q3 2024 Report

Franklin International Growth Fund Q3 2024 Commentary

AAGIY

AAIGF

AAUKF

ABBV

ACHR

ADYEY

ADYYF

ALDX

ALIZF

ALIZY

AMZN

APTV

ASAZF

ASAZY

ASML

ASMLF

BABA

BABAF

BBVA

BBVXF

BEIGF

BEKE

BGNE

BHPLF

BKRKF

BKRKY

BNDSF

BNDSY

BNTX

BRENF

CEVMF

CEVMY

CHGCF

CHGCY

CLPBF

CLPBY

COCSF

CYBR

DASTF

DASTY

DBSDF

DBSDY

DISPF

DSCSY

DSDVF

DSDVY

DSKYF

DSNKY

EVOTF

EXPGY

FMCC

FMCCG

FMCCH

FMCCI

FMCCJ

FMCCK

FMCCL

FMCCM

FMCCN

FMCCO

Comments

Genmab

Genmab (GNMSF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga